120 related articles for article (PubMed ID: 24603404)
1. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer.
Zacherl J
Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404
[TBL] [Abstract][Full Text] [Related]
2. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract][Full Text] [Related]
3. Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy.
Yan Y; Feng X; Li C; Lerut T; Li H
Chin Med J (Engl); 2022 Sep; 135(18):2143-2156. PubMed ID: 36525602
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
Gebauer F; Plum PS; Damanakis A; Chon SH; Popp F; Zander T; Quaas A; Fuchs H; Schmidt T; Schröder W; Bruns CJ
Ann Surg Oncol; 2023 Nov; 30(12):7422-7433. PubMed ID: 37210683
[TBL] [Abstract][Full Text] [Related]
5. Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer.
Fokas E; Rödel C
Viszeralmedizin; 2015 Oct; 31(5):347-53. PubMed ID: 26989391
[TBL] [Abstract][Full Text] [Related]
6. Chances, risks and limitations of neoadjuvant therapy in surgical oncology.
Lordick F; Gockel I
Innov Surg Sci; 2016 Sep; 1(1):3-11. PubMed ID: 31579713
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up').
Cellini F; Manfrida S; Gambacorta MA; Valentini V
Ann Oncol; 2023 Jun; 34(6):553-554. PubMed ID: 36965575
[No Abstract] [Full Text] [Related]
8. Multidisciplinary approach for patients with esophageal cancer.
Villaflor VM; Allaix ME; Minsky B; Herbella FA; Patti MG
World J Gastroenterol; 2012 Dec; 18(46):6737-46. PubMed ID: 23239911
[TBL] [Abstract][Full Text] [Related]
9. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract][Full Text] [Related]
10. Reply to the Letter to the Editor 'Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up")' by Cellini et al.
Obermannová R; Smyth EC;
Ann Oncol; 2023 Jun; 34(6):554-555. PubMed ID: 37295906
[No Abstract] [Full Text] [Related]
11. Multimodal Treatment of Resectable Esophageal Cancer.
Waters J; Sewell M; Molena D
Ann Thorac Surg; 2024 May; ():. PubMed ID: 38777248
[TBL] [Abstract][Full Text] [Related]
12. Controversies in preoperative therapy in esophageal cancer: Current evidence and ongoing research.
Ashok A; Tiwari V; Jiwnani S; Karimundackal G; Pramesh CS
Ann Gastroenterol Surg; 2019 Nov; 3(6):592-597. PubMed ID: 31788647
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer chemotherapy: recent advances.
Ilson DH
Gastrointest Cancer Res; 2008 Mar; 2(2):85-92. PubMed ID: 19259300
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation Alleviates Severe PD-1 Inhibitor-Associated Colitis Caused by Neoadjuvant Therapy for Esophageal Cancer: A Case Report.
Huang X; He X; Chen X; Li Y
Gastroenterol Nurs; 2023 Dec; ():. PubMed ID: 38150616
[TBL] [Abstract][Full Text] [Related]
15. [Multimodal treatment of locally advanced esophageal adenocarcinoma-Neoadjuvant chemoradiotherapy or perioperative chemotherapy?].
Schröder W; Bruns CJ
Chirurgie (Heidelb); 2024 Jun; ():. PubMed ID: 38839689
[No Abstract] [Full Text] [Related]
16. ASO Visual Abstract: Influence of Neoadjuvant Immunotherapy-Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma.
Nevo Y; Tankel J; Zao H; Ramirez J; Cools-Lartigue J; Muller C; Alcindor T; Ferri L
Ann Surg Oncol; 2024 Apr; ():. PubMed ID: 38679680
[No Abstract] [Full Text] [Related]
17. ASO Visual Abstract: Neoadjuvant Chemotherapy Improves Feasibility of Larynx Preservation and Prognosis for Resectable Locally Advanced Cervical Esophageal Cancer.
Kubo Y; Nozaki R; Igaue S; Utsunomiya D; Kubo K; Yamamoto S; Kurita D; Kashihara T; Ishiyama K; Honma Y; Oguma J; Kato K; Daiko H
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38849683
[No Abstract] [Full Text] [Related]
18. Putting Wind in the Sails of Neoadjuvant Therapy for Locally Advanced Esophageal Adenocarcinoma: Perioperative Outcomes.
Meredith LT; Grenda TR
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38858293
[No Abstract] [Full Text] [Related]
19. Correction to: Updates of perioperative multidisciplinary treatment for surgically resectable esophageal cancer.
Jpn J Clin Oncol; 2023 Oct; 53(10):1000-1001. PubMed ID: 37643088
[No Abstract] [Full Text] [Related]
20. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.
Deng J; Wang C; Xiang M; Liu F; Liu Y; Zhao K
Diagn Pathol; 2014 Jul; 9():151. PubMed ID: 25030066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
